316
Views
16
CrossRef citations to date
0
Altmetric
Research Article

New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization

&
Pages 362-368 | Received 17 Jul 2013, Accepted 22 Oct 2013, Published online: 27 Nov 2013
 

Abstract

In this study, a new co-processed excipient composed of microcrystalline cellulose (MCC), sorbitol, chitosan and Eudragit® E, easily obtained by wet massing, to increase the dissolution rate of active ingredients of low water solubility from pellets prepared by extrusion–spheronization is evaluated. Indomethacin, nifedipine, furosemide, ibuprofen, prednisolone and hydrochlorothiazide are used as model drugs of different solubility. All pellet formulations evaluated showed adequate morphological, flow and mechanical properties. Pellets prepared with the co-processed excipient show a higher drug dissolution rate than those prepared with MCC and even higher than the pure drug powder. The fast drug dissolution and the complete disintegration (<3 min) of the pellets can be explained by the great porosity of the formulations, the high solubility of the sorbitol, the disintegrant capacity of the chitosan and the distribution of the Eudragit® E polymer particles in-between the other components of the co-processed mixture. In conclusion, this new co-processed excipient is very suitable to increase the dissolution rate of poorly soluble drugs from pellets prepared by extrusion–spheronization. Moreover, the drug release rate can be estimated from the Ln of the drug solubility in acidic medium.

Acknowledgements

We also thank Roquette Laisa España, S.A. (Spain) and Evonik Industries for the generous gift of samples of sorbitol and Eudragit® E 12.5, respectively.

Declaration of interest

This work was supported by grant 07CSA006203PR from the CII (Xunta de Galicia, Spain) and a post-doctoral fellow from the Fundación Alfonso Martín Escudero.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.